The Indian government has capped the profit margins on many cancer medicines at 30% to make life-saving treatments more affordable for patients. This new rule applies to both branded and generic drugs, whether made in India or imported, and is expected to save patients around ₹500 crores every year. The move follows concerns from the Supreme Court regarding the excessively high prices charged by private hospitals.
While lowering prices is a major step, medical experts emphasize that more needs to be done to tackle the disease effectively. In a recent Sansad TV discussion, health professionals noted that 80% of cancer cases in India are detected in advanced stages, making treatment much more expensive and complex.
To further ease the burden on patients, experts recommend three key changes:
Tracking Cases Early: Making cancer a mandatory reportable disease, similar to dengue, would help local clinics catch and treat cases much earlier.
Promoting Generic Drugs: Doctors should prescribe highly effective, low-cost generic medicines available through government programs instead of costly brand-name alternatives.
Expanding Local Care: Establishing dedicated cancer departments in district medical colleges would save rural patients the time and expense of traveling to major cities like Delhi or Mumbai for treatment.
Ultimately, the government’s goal is to ensure these critical medicines are not only cheaper but also consistently available in local markets, bringing much-needed relief to affected families.